We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$156B
1-Year Est. Return
27.51%
This Fund
S&P 500
This Quarter
Est. Return
+0.74%
1 Year Est. Return
+27.51%
3 Year Est. Return
+75.53%
5 Year Est. Return
+102.92%
10 Year Est. Return
+480.77%
AUM
$156B
AUM Growth
-$21.1B
(-12%)
Cap. Flow
-$19.2B
Cap. Flow
% of AUM
-12.28%
Top 10 Holdings %
Top 10 Hldgs %
18.41%
Holding
2,506
New
88
Increased
1,137
Reduced
1,110
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$697M |
| 2 |
ASML
ASML
|
+$575M |
| 3 |
CRH
CRH
|
+$473M |
| 4 |
ServiceNow
NOW
|
+$442M |
| 5 |
Meta Platforms (Facebook)
META
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.65B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$977M |
| 4 |
Apple
AAPL
|
+$923M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$843M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Financials | 11.5% |
| 3 | Industrials | 11.05% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Healthcare | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Inhibikase Therapeutics
IKT
$366M
| $17.7K | ﹤0.01% |
10,552
-848
| -7% | -$1.51K |
|
2352
Xerox
XRX
$337M
| $17.6K | ﹤0.01% |
13,611
-33
| -0.2% | -$65 |
|
2353
Heron Therapeutics
HRTX
$86.3M
| $17K | ﹤0.01% |
21,233
+319
| +2% | +$370 |
|
2354
Codexis
CDXS
$135M
| $16.4K | ﹤0.01% |
10,081
| – | – |
|
|
ORBS
2355
Eightco Holdings
ORBS
$234M
| $15.9K | ﹤0.01% |
17,059
-167
| -1% | -$214 |
|
|
AIFC
2356
AI Financial Corp
AIFC
$60.6M
| $15.7K | ﹤0.01% |
14,115
+1,798
| +15% | +$2.93K |
|
2357
Quantum-Si Incorporated
QSI
$168M
| $15.3K | ﹤0.01% |
19,808
+11
| +0.1% | +$11 |
|
2358
Innoviz Technologies
INVZ
$135M
| $15.2K | ﹤0.01% |
23,962
+443
| +2% | +$405 |
|
2359
Fate Therapeutics
FATE
$281M
| $15.1K | ﹤0.01% |
12,595
-33
| -0.3% | -$40 |
|
|
LPRO
2360
Open Lending Corp
LPRO
$373M
| $14.5K | ﹤0.01% |
11,617
+192
| +2% | +$304 |
|
2361
New Fortress Energy
NFE
$101M
| $12.8K | ﹤0.01% |
21,770
-146
| -0.7% | -$171 |
|
2362
Tenaya Therapeutics
TNYA
$168M
| $12.8K | ﹤0.01% |
18,491
+843
| +5% | +$622 |
|
2363
Rekor Systems
REKR
$83.8M
| $12.4K | ﹤0.01% |
15,072
+1,021
| +7% | +$1.09K |
|
|
ABTC
2364
American Bitcoin Corp
ABTC
$418M
| $12.3K | ﹤0.01% |
887
-8
| -0.9% | -$154 |
|
2365
Lucid Diagnostics
LUCD
$173M
| $11.6K | ﹤0.01% |
10,113
-722
| -7% | -$919 |
|
2366
Humacyte
HUMA
$168M
| $11.4K | ﹤0.01% |
18,758
+544
| +3% | +$566 |
|
2367
Rackspace Technology
RXT
$1B
| $11K | ﹤0.01% |
11,194
+144
| +1% | +$175 |
|
|
NAKA
2368
Nakamoto Inc
NAKA
$84.7M
| $10.5K | ﹤0.01% |
1,189
+75
| +7% | +$949 |
|
|
SGMO
2369
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $10.4K | ﹤0.01% |
42,040
+4,156
| +11% | +$1.65K |
|
2370
GoPro
GPRO
$116M
| $10.3K | ﹤0.01% |
13,338
-60
| -0.4% | -$60 |
|
2371
SelectQuote
SLQT
$114M
| $9.88K | ﹤0.01% |
15,697
-83
| -0.5% | -$87 |
|
2372
BRC Inc
BRCC
$126M
| $9.42K | ﹤0.01% |
12,137
+51
| +0.4% | +$43 |
|
2373
Blink Charging
BLNK
$75.2M
| $8.71K | ﹤0.01% |
15,365
+2,798
| +22% | +$1.97K |
|
2374
Westwater Resources
WWR
$51M
| $8.18K | ﹤0.01% |
12,506
-118
| -0.9% | -$106 |
|
2375
MaxCyte
MXCT
$116M
| $7.93K | ﹤0.01% |
11,283
-30
| -0.3% | -$28 |
|
Similar funds
Victory Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Victory Capital Management held 2,506 positions worth $156B, down 12% from $177B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Victory Capital Management withdrew a net $19.2B in Q1 2026, closing 97 positions and reducing 1,110 holdings. Its most notable exit was iShares MSCI Emerging Markets ex China ETF, an estimated $136M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Financials and Industrials.
Against the trend, Victory Capital Management opened a new position in Amrize Ltd worth $218M.
- Victory Capital Management's largest Q1 2026 buy was Amrize Ltd: 3,886,958 shares worth $218M.
- Victory Capital Management added most to Accenture in Q1 2026, an estimated $697M increase.
- Victory Capital Management's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.65B.
- Victory Capital Management fully exited iShares MSCI Emerging Markets ex China ETF in Q1 2026, selling an estimated $136M.
- Victory Capital Management's ten largest holdings make up 18% of its $156B portfolio in Q1 2026.
- Victory Capital Management opened 88 new positions and closed 97 in Q1 2026.
- Victory Capital Management's portfolio value fell 12% quarter-over-quarter to $156B.
Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.